Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts said.
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
Three Democratic senators want answers from Health and Human Services Secretary Robert F. Kennedy Jr. about his private meetings with drugmakers alongside President Trump at his Mar-a-Lago club in ...
An opaque system of rebates and discounts makes understanding a drug’s true price near impossible, even for experts. Can ...
The drugmakers are discussing the terms of a transaction that would give each of them roughly 50% ownership of the combined entity, Bloomberg News, which first reported the deal, said, adding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback